| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 08/06/2003 | CN1434797A Hydrazone and oxime derivatives of pyrrolidine as AMP-specific phosphodiesterase inhibitons |
| 08/06/2003 | CN1434792A Purification of xanthophylls from marigold extracts that contain high levels of chlorophylls |
| 08/06/2003 | CN1434727A Anglogenesis and vascular permeability modulators and inhibitors |
| 08/06/2003 | CN1434712A Nitrosated and nitrosylated cyclooxygenase-2 inhibitors compositions and methods of use |
| 08/06/2003 | CN1434705A Use of hydroxide-releasing agents as skin permeation enhancers |
| 08/06/2003 | CN1433786A Traditional Chinese medicine composition for treating myopia and preparation process thereof |
| 08/06/2003 | CN1433778A Powder medicine for treating otitis media and preparation method thereof |
| 08/06/2003 | CN1433775A Long-ncting heparin intraocular slow-released system |
| 08/06/2003 | CN1433755A Long-acting tretnoin intraocular slow-releasing system |
| 08/06/2003 | CN1117077C 6-phenylpyridyl-2-amine derivatives useful asNOS inhibitors |
| 08/06/2003 | CN1116886C Process for preparing Chinese-medicinal pills containing borneol |
| 08/05/2003 | US6603008 Sulfamoylheleroaryl pyrazole compounds as anti-inflammatory/analgesic agents |
| 08/05/2003 | US6602881 Anti-inflammatory uses of manzamines |
| 08/05/2003 | US6602878 Acylquanidine derivatives, method for preparing same, application as medicines and pharmaceutical compositions containing them |
| 08/05/2003 | CA2275827C Method for treating glaucoma |
| 08/05/2003 | CA2272665C Method of treating glaucoma and ischemic retinopathy |
| 07/31/2003 | WO2003062392A2 Methods of treating conditions associated with an edg receptor |
| 07/31/2003 | WO2003062370A2 Multimeric proteins and methods of making and using same |
| 07/31/2003 | WO2003062278A1 MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR |
| 07/31/2003 | WO2003062275A1 Glycoisoforms of adiponectin and uses thereof |
| 07/31/2003 | WO2003062252A1 Edg receptor agonists |
| 07/31/2003 | WO2003062248A2 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
| 07/31/2003 | WO2003062243A1 Novel compounds as semaphorin inhibitors |
| 07/31/2003 | WO2003062227A1 Rho-kinase inhibitors |
| 07/31/2003 | WO2003062225A1 Pyrimidine derivatives as rho-kinase inhibitors |
| 07/31/2003 | WO2003062200A2 Fluoro substituted cycloalkanoindoles and their use as prostaglandin d2 receptor antagonists |
| 07/31/2003 | WO2003061699A1 Remedies for allergic diseases |
| 07/31/2003 | WO2003061696A2 Systems and methods for photodynamic therapy |
| 07/31/2003 | WO2003061658A1 Sigma receptor binder containing indanone derivative |
| 07/31/2003 | WO2003061655A1 2-aminothiazole allosteric enhancers of a1 adenosine receptors |
| 07/31/2003 | WO2003061645A1 Pharmaceutical use of cox-2 inhibitors in angiogenesis-mediated ocular disorders |
| 07/31/2003 | WO2003061626A1 Polymeric gel system for the controlled delivery of codrugs |
| 07/31/2003 | WO2003061563A2 Method of preparing delta-9 tetrahydrocannabinol |
| 07/31/2003 | WO2003035679A3 Molecules |
| 07/31/2003 | WO2003025140A3 Transductin-1 and transductin-2 and applications to hereditary deafness |
| 07/31/2003 | WO2003006016A3 Use of nk-1 receptor antagonists with pyridinic structure, for the treatment of brain, spinal or nerve injury |
| 07/31/2003 | WO2002100408A3 Treating neuropathic/inflammatory pain by targeting a composition (e.g. zd7288) to hcn pacemaker channels |
| 07/31/2003 | WO2002094202B1 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 07/31/2003 | WO2002060875A8 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes |
| 07/31/2003 | WO2002060464A3 Compositions containing an active fraction isolated from hedyotis diffusae and methods of use |
| 07/31/2003 | WO2002029038A3 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 07/31/2003 | WO2002018361A3 Compounds having activity as inhibitors of cytochrome p450rai |
| 07/31/2003 | US20030144347 Method for treating autoimmune disease |
| 07/31/2003 | US20030144335 Nitroimidazole compound for allergic conjunctivitis or allergic rhinitis |
| 07/31/2003 | US20030144328 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/31/2003 | US20030144326 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 07/31/2003 | US20030144323 Phenylalkynes |
| 07/31/2003 | US20030144311 Propanoic acid derivatives as intergrin receptor antagonists |
| 07/31/2003 | US20030144302 Process for making substituted pyrazoles |
| 07/31/2003 | US20030144300 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes |
| 07/31/2003 | US20030144298 Therapeutic combinations of antihypertensive and antiangiogenics agents |
| 07/31/2003 | US20030144293 N-alkyl-adamantyl triazinyl benzamide derivatives |
| 07/31/2003 | US20030144280 Heterocyclic imines, used as cyclooxygenase inhibitors, administered as inflammatory and pain relievers in disorders such as arthritis, neurodegeneration or cancer in mammals |
| 07/31/2003 | US20030144279 5-Heterocyclo-pyrazoles |
| 07/31/2003 | US20030144270 Neurokinin receptor antagonists comprising heterocyclic amides used as antiemetics, antidepressants and/or antitussive agents |
| 07/31/2003 | US20030144267 Novel compounds |
| 07/31/2003 | US20030144247 Obtained by reacting polyalkylene glycol or a reactive derivative, a phospholipid and a drug with each other to form covalent bonds to form a delivery substance |
| 07/31/2003 | US20030144210 Treatment of neurologic and psychiatric disorders |
| 07/31/2003 | US20030144206 Combined use of a GLP-1 compound and modulator of diabetic late complications |
| 07/31/2003 | US20030144203 Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 07/31/2003 | US20030143633 Factors participating in degranulation of mast cells, dnas encoding the same, method of screening of these factors and the inhibitors |
| 07/31/2003 | US20030143589 Drug metabolizing enzymes |
| 07/31/2003 | US20030143588 Phosphodiesterases |
| 07/31/2003 | US20030143271 For therapy and prophylaxis of cyclooxygenase-2 mediated disorder and for providing cardioprotection |
| 07/31/2003 | US20030143157 Method of treating tumors |
| 07/31/2003 | CA2476773A1 Monoclonal antibodies against extracellular loops of c5ar |
| 07/31/2003 | CA2473924A1 Systems and methods for photodynamic therapy |
| 07/31/2003 | CA2473781A1 Glycoisoforms of adiponectin and uses thereof |
| 07/31/2003 | CA2473740A1 Methods of treating conditions associated with an edg receptor |
| 07/31/2003 | CA2473510A1 Pyrimidine derivatives as rho-kinase inhibitors |
| 07/31/2003 | CA2471989A1 2-aminothiazole allosteric enhancers of a1 adenosine receptors |
| 07/31/2003 | CA2454358A1 Multimeric proteins and methods of making and using same |
| 07/30/2003 | EP1330455A1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 07/30/2003 | EP1330453A1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 07/30/2003 | EP1330452A2 Pyrazine derivatives as modulators of tyrosine kinases |
| 07/30/2003 | EP1330448A2 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 07/30/2003 | EP1330436A1 N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr3-3 receptor antagonists |
| 07/30/2003 | EP1330268A1 Targeted therapeutic agents |
| 07/30/2003 | EP1330246A1 Use of hydroxyeicosatetraenoic acid derivatives in intraocular surgery |
| 07/30/2003 | EP1330166A1 Food grade transglutaminase inhibitor and uses thereof |
| 07/30/2003 | EP1181288B1 Bicyclic oxazolidinones as antibacterial agent |
| 07/30/2003 | EP1075256B1 Arylhydrocarbon receptor ligand antagonists |
| 07/30/2003 | EP0946541B1 Quinolines and their therapeutic use |
| 07/30/2003 | EP0832198B1 Oxygen activatable formulations for disinfection or sterilization |
| 07/30/2003 | CN1433411A Chemical compounds |
| 07/30/2003 | CN1433405A Quinazoline compounds |
| 07/30/2003 | CN1433318A Vascular endothelial growth factor-2 |
| 07/29/2003 | US6600037 4,5-disubstituted-2-aminopyrimidines |
| 07/29/2003 | US6600013 Moraxella catarrhalis BASB034 polypeptides and uses thereof |
| 07/29/2003 | US6599944 Ophtalmic compound with extended dwell time on the eye |
| 07/29/2003 | US6599925 Cardiovascular disorders; anticancer agents |
| 07/29/2003 | US6599910 Substituted triazole compounds |
| 07/29/2003 | US6599891 Administering to the subject an amount of a photosensitizer (PS) sufficient to allow said photosensitizer to localize in lesion; irradiating said lesion with light having a wavelength absorbed by said PS |
| 07/29/2003 | US6599879 Therapeutic uses of keratinocyte growth factor-2 |
| 07/29/2003 | US6599499 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 07/29/2003 | CA2210444C Keratinocyte growth factor-2 |
| 07/29/2003 | CA2056065C Preparation of 3-alkylated indoles |
| 07/24/2003 | WO2003060085A2 Mammalian neural stem cells, compositions and uses thereof |
| 07/24/2003 | WO2003060082A2 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 07/24/2003 | WO2003059921A1 Mmp inhibitors |